HK1005016A1 - Use of buspirone in sleep apneas - Google Patents

Use of buspirone in sleep apneas

Info

Publication number
HK1005016A1
HK1005016A1 HK98104204A HK98104204A HK1005016A1 HK 1005016 A1 HK1005016 A1 HK 1005016A1 HK 98104204 A HK98104204 A HK 98104204A HK 98104204 A HK98104204 A HK 98104204A HK 1005016 A1 HK1005016 A1 HK 1005016A1
Authority
HK
Hong Kong
Prior art keywords
buspirone
sleep apneas
apneas
sleep
useful
Prior art date
Application number
HK98104204A
Other languages
English (en)
Inventor
William C Dement
Mark R Rosekind
Jeffrey L Schwimmer
Original Assignee
Bristol Myers Squibb Co
Univ Stanford
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co, Univ Stanford filed Critical Bristol Myers Squibb Co
Publication of HK1005016A1 publication Critical patent/HK1005016A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK98104204A 1990-02-12 1998-05-15 Use of buspirone in sleep apneas HK1005016A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47980390A 1990-02-12 1990-02-12

Publications (1)

Publication Number Publication Date
HK1005016A1 true HK1005016A1 (en) 1998-12-18

Family

ID=23905511

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104204A HK1005016A1 (en) 1990-02-12 1998-05-15 Use of buspirone in sleep apneas

Country Status (12)

Country Link
EP (1) EP0442423B1 (xx)
JP (1) JP3168543B2 (xx)
KR (1) KR910015300A (xx)
AT (1) ATE116854T1 (xx)
CA (1) CA2036055A1 (xx)
DE (1) DE69106543T2 (xx)
DK (1) DK0442423T3 (xx)
ES (1) ES2069758T3 (xx)
GR (1) GR3015716T3 (xx)
HK (1) HK1005016A1 (xx)
HU (1) HUT56496A (xx)
IL (1) IL97054A (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
US7160898B2 (en) 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
EP1066036B1 (en) * 1998-02-27 2006-04-26 The Board Of Trustees Of The University Of Illinois Agents with serotonin-related activity for the treatment for sleep apnea
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
US8512751B2 (en) 2004-12-20 2013-08-20 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
MX2008000250A (es) 2005-07-06 2008-03-19 Sepracor Inc Combinaciones de eszopiclona y trans-4-(3,4-diclorofenil)-1,2,3,4- tetrahidro-n-metil-1-naftalenamina o trans 4-(3,4-diclorofenil)-1, 2,3,4-tetrahidro-1-naftalenamina y metodos de tratamiento de menopausia y trastornos del estado de animo, ansiedad y
CN101421228B (zh) 2006-03-31 2014-05-21 塞普拉柯公司 手性酰胺和胺的制备
EP2429514A1 (en) * 2009-05-13 2012-03-21 Sunovion Pharmaceuticals Inc. Compositions comprising transnorsertraline and serotonin receptor 1a agonists/ antagonists and uses thereof

Also Published As

Publication number Publication date
JP3168543B2 (ja) 2001-05-21
IL97054A0 (en) 1992-03-29
DK0442423T3 (da) 1995-03-20
JPH0826997A (ja) 1996-01-30
IL97054A (en) 1995-10-31
KR910015300A (ko) 1991-09-30
EP0442423B1 (en) 1995-01-11
DE69106543T2 (de) 1995-05-11
ES2069758T3 (es) 1995-05-16
HUT56496A (en) 1991-09-30
HU910436D0 (en) 1991-08-28
DE69106543D1 (de) 1995-02-23
CA2036055A1 (en) 1991-08-13
GR3015716T3 (en) 1995-07-31
ATE116854T1 (de) 1995-01-15
EP0442423A1 (en) 1991-08-21

Similar Documents

Publication Publication Date Title
EP0441119A3 (en) The use of l-arginine in the treatment of hypertension and other vascular disorders
CY1831A (en) Antimigraine alkoxypyrimidine derivatives
EP0276536A3 (en) Use of buspirone for the improvement of short term memory
HU913137D0 (en) 2-amino-4-carboxamido-pirimidine derivatives, their production and medical use
GR3015716T3 (en) Use of buspirone in sleep apneas.
Mullen Issues in the morphology and phonology of Amharic the lexical generation of pronominal clitics.
ZA918074B (en) N-(2-alkyl-3-mercaptoglutaryl)-amino-diaza cycloakanone derivatives and their use as collage/nase inhibitors.
IL98075A0 (en) Azabenzimidazoles in the treatment of asthma,arthritis and related diseases
HU910917D0 (en) Machine for the straightening and evening of rail beds
EP0496148A3 (en) Improvements in the treatment of ashes
GB8800491D0 (en) Sleep apnoea monitor
GB2240405B (en) Ophthalmic measures and templates
AU111262S (en) A nappy
ZA896334B (en) Use of zofenopril for the treatment of rheumatoid arthritis
DE69121210T2 (de) Therapeutische verwendung des fibroblastenwachstumsfaktors
GR3002925T3 (en) Compound active in cardiovascular therapy
ITMI941939A0 (it) Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
GB2230443B (en) Treatment of sleep apnoea
AU2153092A (en) Spirofurane derivatives and their use in the treatment of neurological disorders
EP0407016A3 (en) Use of benzodioxinopyrrole derivatives in the treatment of anxiety
SE9403861D0 (sv) Novel medicinal use
GB9319940D0 (en) Variable impedance in the treatment of sleep apnea
ZA9210003B (en) The use of n'-substituted n-phenylsulphonylureas in the treatment of hypertension in insulin-resistant subjects
GR900100214A (el) Ασφαλιστική παροχή αίματος και παραγώγων αίματος.
ZA917747B (en) Vaccine formulations and their manufacture and use in the treatment of aids

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20050211